SCHEMBL3422962

SCHEMBL3422962

Nc1cccc(-c2nnc(-c3cccc(N)c3)o2)c1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MECP2 P51608 1/20 0.89
ATAD2 Q6PL18 1/20 0.70
NPC1 O15118 13/20 0.61
RAB9A P51151 12/20 0.61
SMN1; SMN2 Q16637 7/20 0.61
ALDH1A1 P00352 5/20 0.61
HPGD P15428 4/20 0.61
TP53 P04637 3/20 0.61
HSD17B10 Q99714 2/20 0.61
POLB P06746 1/20 0.61
KMT2A Q03164 3/20 0.59
MEN1 O00255 2/20 0.59
KDM4E B2RXH2 4/20 0.57
MAPT P10636 3/20 0.57
GLA P06280 1/20 0.57
ALOX15 P16050 1/20 0.57
TSHR P16473 3/20 0.53
NFKB1 P19838 2/20 0.53
NFKB2 Q00653 2/20 0.53
RELA Q04206 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29813232 1.00 MECP2 (0.89) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL653811 0.94 MECP2 (1.00) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL1142913 0.92 MECP2 (0.83) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL11508555 0.92 MECP2 (0.83) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL653790 0.89 NPC1 (0.72) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL3910760 0.87 MECP2 (0.69) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL2835027 0.87 MECP2 (0.69) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL2214351 0.87 MECP2 (0.69) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL29454527 0.86 MECP2 (0.68) MECP2ATAD2NPC1RAB9ASMN1; SMN2
SCHEMBL1543902 0.85 MECP2 (0.67) MECP2ATAD2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080015193-A1 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof AGRIUS GROUP, LLC. 2008-01-17 US claimed
WO-2007149395-A2 2,5-SUBSTITUTED OXAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AMPHORA DISCOVERY CORPORATION (US) 2007-12-27 WO claimed
US-4526835-A Prepreg resin sheets formed by impregnating reinforcing substrate with curable polyimide, binding laminated sheets with heat, pressure HITACHI, LTD. (JP) 1985-07-02 US claimed
US-4486583-A MOLDING MATERIALS, COATINGS HITACHI, LTD. (JP) 1984-12-04 US claimed
US-4393188-A PRINTED CIRCUITS HITACHI CHEMICAL COMPANY, LTD. (JP) 1983-07-12 US claimed
US-4390596-A POLYAMINE, BIS-MALEIMIDE, FREE RADICAL CATALYST, FILLER RHONE-POULENC INDUSTRIES (FR) 1983-06-28 US claimed
US-4283522-A BY HEATING WITH A DIAMINE HITACHI CHEMICAL COMPANY, LTD. (JP) 1981-08-11 US claimed
US-4238591-A BIS-MALEIMIDE, SILANEDIOL OR SILOXANE RHONE-POULENC INDUSTRIES (FR) 1980-12-09 US claimed
US-11965060-B2 Fluorine-containing epoxy resin for electrical materials and method for manufacturing same DAIKIN INDUSTRIES, LTD. (JP) 2024-04-23 US disclosed
US-20220298294-A1 COMPOSITION, CURABLE COMPOSITION, AND CURED PRODUCT DAIKIN INDUSTRIES, LTD. (JP) 2022-09-22 US disclosed
EP-4053214-A1 COMPOSITION, CURABLE COMPOSITION, AND CURED PRODUCT Daikin Industries, Ltd. (JP) 2022-09-07 EP disclosed
US-20220219127-A1 POLY(IMIDE-OXADIAZOLE) MEMBRANES FOR GAS SEPARATION APPLICATIONS SAUDI ARABIAN OIL COMPANY (SA) 2022-07-14 US disclosed
US-20220081507-A1 FLUORINE-CONTAINING EPOXY RESIN FOR ELECTRICAL MATERIALS AND METHOD FOR MANUFACTURING SAME DAIKIN INDUSTRIES, LTD. (JP) 2022-03-17 US disclosed
EP-3960788-A1 FLUORINE-CONTAINING EPOXY RESIN FOR ELECTRICAL MATERIALS AND METHOD FOR MANUFACTURING SAME DAIKIN INDUSTRIES, LTD. (JP) 2022-03-02 EP disclosed
US-4010220-A AMINO COMPOUND, POLYURETHANE ELASTOMER RHONE-POULENC INDUSTRIES (FR) 1977-03-01 US disclosed
US-4005154-A Curing 1,2-epoxy with prepolymer based on polyamines and oligomers possessing imide groups RHONE-POULENC S.A. (FR) 1977-01-25 US disclosed
US-3998904-A POLYAMINES WITH IMIDE GROUPS RHONE-POULENC S.A. (FR) 1976-12-21 US disclosed
US-3970714-A Heat-stable polyimide resin modified by unsaturated polyester RHONE-POULENC S.A. (FR) 1976-07-20 US disclosed
US-3966678-A Maleic anhydride-polyaldimine prepolymers RHONE-POULENC S.A. (FR) 1976-06-29 US disclosed
US-3933745-A Imide copolymers possessing hydroxyl groups RHONE-POULENC S.A. (FR) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015193-A1 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof ATP5ME, ATP5MG, ATP5MK MECP2 4377/4885ATAD2 531/4885NPC1 2981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.